First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. 1986

M Koskela, and M Leinonen, and V M Häivä, and M Timonen, and P H Mäkelä

Total (radioimmunoassay) and immunoglobulin class-specific (enzyme-linked immunosorbent assay) antibody responses to pneumococcal capsular polysaccharides were measured in children who received the first dose of 14-valent pneumococcal or control (saline) vaccine at the age of 7 months and the second dose at the age of 13 months. Types 3 and 18C elicited strong antibody responses and types 14 and 19F elicited intermediate responses in all immunoglobulin classes after both doses of the vaccine. The generally poor immunogen types 6A and 23F elicited a weak antibody response mainly in the immunoglobulin M class. The antibody levels to most pneumococcal types also decreased rapidly after both injections of the vaccine.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007115 Immunization Schedule Schedule giving optimum times usually for primary and/or secondary immunization. Immunization Schedules,Schedule, Immunization,Schedules, Immunization
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D007223 Infant A child between 1 and 23 months of age. Infants
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies

Related Publications

M Koskela, and M Leinonen, and V M Häivä, and M Timonen, and P H Mäkelä
November 1984, Pediatric research,
M Koskela, and M Leinonen, and V M Häivä, and M Timonen, and P H Mäkelä
January 1996, The Journal of infectious diseases,
M Koskela, and M Leinonen, and V M Häivä, and M Timonen, and P H Mäkelä
December 1997, The Pediatric infectious disease journal,
M Koskela, and M Leinonen, and V M Häivä, and M Timonen, and P H Mäkelä
August 2016, Clinical and experimental immunology,
M Koskela, and M Leinonen, and V M Häivä, and M Timonen, and P H Mäkelä
January 1980, The Annals of otology, rhinology & laryngology. Supplement,
M Koskela, and M Leinonen, and V M Häivä, and M Timonen, and P H Mäkelä
June 1990, Scandinavian journal of immunology,
M Koskela, and M Leinonen, and V M Häivä, and M Timonen, and P H Mäkelä
February 1980, The Journal of pediatrics,
M Koskela, and M Leinonen, and V M Häivä, and M Timonen, and P H Mäkelä
December 1980, JAMA,
M Koskela, and M Leinonen, and V M Häivä, and M Timonen, and P H Mäkelä
July 2009, The Journal of rheumatology,
M Koskela, and M Leinonen, and V M Häivä, and M Timonen, and P H Mäkelä
March 2007, Journal of the Formosan Medical Association = Taiwan yi zhi,
Copied contents to your clipboard!